The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 12, 2016
Filed:
Sep. 06, 2012
Applicants:
Asim Kumar Debnath, New York, NY (US);
Francesca Curreli, New York, NY (US);
Peter D. Kwong, Bethesda, MD (US);
Young DO Kwon, Bethesda, MD (US);
Inventors:
Asim Kumar Debnath, New York, NY (US);
Francesca Curreli, New York, NY (US);
Peter D. Kwong, Bethesda, MD (US);
Young Do Kwon, Bethesda, MD (US);
Assignees:
NEW YORK BLOOD CENTER, INC., New York, NY (US);
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, Washington, DC (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/425 (2006.01); A61K 31/41 (2006.01); A61K 31/445 (2006.01); A61K 31/50 (2006.01); A61K 31/535 (2006.01); C07D 417/14 (2006.01); A61K 45/06 (2006.01); A61K 31/167 (2006.01); A61K 31/341 (2006.01); A61K 31/40 (2006.01); A61K 31/427 (2006.01); A61K 31/4402 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); A61K 31/538 (2006.01); A61K 31/55 (2006.01); C07D 211/14 (2006.01); C07D 223/04 (2006.01); C07D 307/54 (2006.01); C07D 417/06 (2006.01); A61K 31/4439 (2006.01); A61K 31/47 (2006.01); C07D 213/81 (2006.01); C07D 215/12 (2006.01); C07D 231/40 (2006.01); C07D 233/58 (2006.01); C07D 401/06 (2006.01); C07D 487/04 (2006.01); C07D 207/16 (2006.01); C07D 211/42 (2006.01); C07D 211/46 (2006.01); C07D 211/58 (2006.01); C07D 295/192 (2006.01); C07D 295/26 (2006.01); C07D 307/52 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/167 (2013.01); A61K 31/341 (2013.01); A61K 31/40 (2013.01); A61K 31/427 (2013.01); A61K 31/4402 (2013.01); A61K 31/445 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/47 (2013.01); A61K 31/495 (2013.01); A61K 31/538 (2013.01); A61K 31/5375 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01); C07D 207/16 (2013.01); C07D 211/14 (2013.01); C07D 211/42 (2013.01); C07D 211/46 (2013.01); C07D 211/58 (2013.01); C07D 213/81 (2013.01); C07D 215/12 (2013.01); C07D 223/04 (2013.01); C07D 231/40 (2013.01); C07D 233/58 (2013.01); C07D 295/192 (2013.01); C07D 295/26 (2013.01); C07D 307/52 (2013.01); C07D 307/54 (2013.01); C07D 401/06 (2013.01); C07D 417/06 (2013.01); C07D 487/04 (2013.01);
Abstract
Chemical compounds that inhibit retroviruses are presented herein. More particularly, this disclosure provides small molecule compounds that inhibit infection with, or treat infection caused by, human immunodeficiency viruses.